Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Delivering Innovation to the Global Market The Israeli Innovation Model and the Role of Technology Transfer Nava Swersky S...
Nava Swersky Sofer <ul><li>Big pharma 1991-1995 </li></ul><ul><ul><li>VP, Ciba-Geigy AG (now Novartis), Switzerland </li><...
Israeli Innovation
Israel An Innovation Powerhouse <ul><li>Innovative:  1 st  in R&D investments with  4.5% of GDP </li></ul><ul><li>Globally...
Government’s Major Role: Office of the Chief Scientist <ul><li>Established 1969 </li></ul><ul><li>R&D support  </li></ul><...
Magnet Provides Unique Tech Transfer Support <ul><li>Royalty-free OCS grants support industry-academia collaborations </li...
Incubators Bridge Academia & Market <ul><li>Original 1991 job creation scheme turns into growth engine </li></ul><ul><li>G...
Tech Transfer:  The Secret Engine <ul><li>World pioneer in tech transfer since 1959 </li></ul><ul><li>Two of world’s top 1...
The Israeli Tech Transfer Model <ul><li>Company, not office </li></ul><ul><ul><li>Wholly owned subsidiary with business fo...
One Example: Yissum <ul><li>Over $1.3 Billion annual sales of Hebrew University-based products </li></ul><ul><ul><li>Exelo...
Yissum’s 2008 Numbers <ul><li>$60 million in revenues </li></ul><ul><ul><li>Including industry-sponsored research </li></u...
Yissum 2005-2008 <ul><li>Revenues up 76%, from $34 mil to $60 mil </li></ul><ul><li>Licensed product pipeline up 50% </li>...
Tech Transfer Key Success Factors  <ul><li>Create the right environment </li></ul><ul><ul><li>Business-focused organisatio...
Upcoming SlideShare
Loading in …5
×

Israel: An Innovation Powerhouse

2,302 views

Published on

  • Be the first to comment

Israel: An Innovation Powerhouse

  1. 1. Delivering Innovation to the Global Market The Israeli Innovation Model and the Role of Technology Transfer Nava Swersky Sofer IFC TTF Convocation Washington, DC 14-15 May 2009
  2. 2. Nava Swersky Sofer <ul><li>Big pharma 1991-1995 </li></ul><ul><ul><li>VP, Ciba-Geigy AG (now Novartis), Switzerland </li></ul></ul><ul><li>Venture capital 1995-2005 </li></ul><ul><ul><li>Partner, Sanderling Ventures, California </li></ul></ul><ul><ul><li>Founder & Managing Partner, Columbine Ventures, Israel </li></ul></ul><ul><ul><li>Partner, Concord Ventures, Israel </li></ul></ul><ul><li>Start-up company management and boards in US, Europe and Israel </li></ul><ul><li>Tech transfer since 2005 </li></ul><ul><ul><li>President & CEO, Yissum – Hebrew University Technology Transfer 2005-2008 </li></ul></ul><ul><ul><li>International advisor </li></ul></ul><ul><li>Government & public </li></ul><ul><ul><li>Israel’s $50 mil biotech consortium under OCS, 2000 </li></ul></ul><ul><ul><li>BioJerusalem board, 2006-2009; Israel Tech Transfer Organization (ITTN) board, 2008 </li></ul></ul><ul><ul><li>Ontario Centers of Excellence Center for Commercialization of Research, since 2008 </li></ul></ul><ul><ul><li>NanoIsrael 2009, 2010 co-chairperson </li></ul></ul>
  3. 3. Israeli Innovation
  4. 4. Israel An Innovation Powerhouse <ul><li>Innovative: 1 st in R&D investments with 4.5% of GDP </li></ul><ul><li>Globally open </li></ul><ul><ul><li>4th most positive towards globalisation </li></ul></ul><ul><ul><li>Second largest no. of NASDAQ-traded companies after US; >60 Israeli companies traded in Europe </li></ul></ul><ul><li>Entrepreneurial </li></ul><ul><ul><li>1 st in start-ups per capita </li></ul></ul><ul><ul><li>2 nd in business entrepreneurship </li></ul></ul><ul><li>World-class science </li></ul><ul><ul><li>3 rd in quality of scientific research institutions </li></ul></ul><ul><ul><li>4 Nobel prizes in past 5 years </li></ul></ul><ul><li>Human capital </li></ul><ul><ul><li>2 nd in availability of qualified scientists & engineers </li></ul></ul><ul><li>3 rd in VC availability </li></ul>Source: IMD World Competitiveness Report, 2008; World Economic Form Competitiveness Report, 2008-9
  5. 5. Government’s Major Role: Office of the Chief Scientist <ul><li>Established 1969 </li></ul><ul><li>R&D support </li></ul><ul><li>Bi-national funds </li></ul><ul><li>VC industry creation through Yozma funds </li></ul><ul><li>Start-up support – Tnufa, Heznek </li></ul><ul><li>Incubators </li></ul><ul><li>Academia-industry collaborations – Magnet </li></ul>
  6. 6. Magnet Provides Unique Tech Transfer Support <ul><li>Royalty-free OCS grants support industry-academia collaborations </li></ul><ul><li>66%-90% funding </li></ul><ul><li>Easy, inexpensive access point for industry </li></ul><ul><li>Programmes: </li></ul><ul><ul><li>Magnet </li></ul></ul><ul><ul><ul><li>Multi-participant industry-academia consortia </li></ul></ul></ul><ul><ul><ul><li>3-6 years, 66% of industry budget and 80% of academic budget covered; remaining academic budget covered by industry </li></ul></ul></ul><ul><ul><li>Magneton </li></ul></ul><ul><ul><ul><li>One on one industry-academia collaborations </li></ul></ul></ul><ul><ul><ul><li><2 years, NIS 3.4 mil ($810k) of which 66% funded </li></ul></ul></ul><ul><ul><li>Nofar : $100k proof of concept 90% funded by gov’t, 10% by company which gets ‘first look’ </li></ul></ul><ul><ul><li>Katamon: w ater only; academia/industry/infrastructure </li></ul></ul>
  7. 7. Incubators Bridge Academia & Market <ul><li>Original 1991 job creation scheme turns into growth engine </li></ul><ul><li>Gov’t funds 85% of 2 year, $350-600k programme </li></ul><ul><ul><li>Biotech can receive third year </li></ul></ul><ul><li>24 incubators incl. 15 peripheral, 1 biotech </li></ul><ul><li>200 ongoing projects </li></ul><ul><li>60% in life sciences </li></ul><ul><li>1,100 graduated companies, of which </li></ul><ul><ul><li>59% received follow-on funding, 40% still active </li></ul></ul><ul><li>Total $2 Billion raised, a 4.5x leverage on gov’t funding </li></ul><ul><li>Privatisation attracts professional investors </li></ul>
  8. 8. Tech Transfer: The Secret Engine <ul><li>World pioneer in tech transfer since 1959 </li></ul><ul><li>Two of world’s top 15 tech transfer companies </li></ul><ul><ul><li>Yeda, Weizmann Institute of Science (1959) </li></ul></ul><ul><ul><li>Yissum, Hebrew University of Jerusalem (1964) </li></ul></ul><ul><li>>$8 Billion in licensed product sales </li></ul><ul><li>$ hundreds of millions in tech transfer revenues </li></ul><ul><li>Dozens of spin-off companies </li></ul><ul><li>Success stories </li></ul><ul><ul><li>Copaxone®, Exelon™, Erbitux®, Azilect™, Doxil™, Rebif®, Cherry tomatoes, peppers, NDS Ltd. encryption algorithm, MobilEye Ltd. driver assistance system </li></ul></ul>Source: ITTN
  9. 9. The Israeli Tech Transfer Model <ul><li>Company, not office </li></ul><ul><ul><li>Wholly owned subsidiary with business focus </li></ul></ul><ul><li>Business leaders on boards </li></ul><ul><ul><li>Balance academic viewpoint </li></ul></ul><ul><li>Clear IP ownership… </li></ul><ul><li>… with generous revenue sharing (40-60%) </li></ul><ul><li>One-stop-shop for industry – leverage relationship </li></ul><ul><ul><li>Sponsored research + licensing </li></ul></ul><ul><ul><li>Sometimes consulting </li></ul></ul><ul><li>Focused on royalties </li></ul>
  10. 10. One Example: Yissum <ul><li>Over $1.3 Billion annual sales of Hebrew University-based products </li></ul><ul><ul><li>Exelon™ 2008 sales by Novartis $815 mil </li></ul></ul><ul><ul><li>Doxil™ 2008 sales by J&J $430 mil </li></ul></ul><ul><ul><li>Tomato and pepper seeds </li></ul></ul><ul><li>5,500 patents </li></ul><ul><li>1,600 inventions </li></ul><ul><li>480 licenses </li></ul><ul><li>70 spin-offs </li></ul>
  11. 11. Yissum’s 2008 Numbers <ul><li>$60 million in revenues </li></ul><ul><ul><li>Including industry-sponsored research </li></ul></ul><ul><li>60 new patents granted </li></ul><ul><li>128 new inventions </li></ul>
  12. 12. Yissum 2005-2008 <ul><li>Revenues up 76%, from $34 mil to $60 mil </li></ul><ul><li>Licensed product pipeline up 50% </li></ul><ul><li>Non-healthcare up from 1/3 to ½ </li></ul><ul><li>1,200 agreements signed, including 120 license and option </li></ul><ul><ul><li>2.3x increase over previous 3 year period </li></ul></ul><ul><li>New acceleration programmes </li></ul><ul><ul><li>Baby Seed </li></ul></ul><ul><ul><li>Cleantech </li></ul></ul><ul><li>New clients </li></ul><ul><li>Excellent team, best practices, state of the art systems </li></ul>
  13. 13. Tech Transfer Key Success Factors <ul><li>Create the right environment </li></ul><ul><ul><li>Business-focused organisation with operational independence </li></ul></ul><ul><ul><li>Clear IP ownership </li></ul></ul><ul><ul><li>Generous revenue-sharing policy </li></ul></ul><ul><ul><li>An excellent team with relevant industry experience </li></ul></ul><ul><li>Get lucky! </li></ul>

×